Na 2021-12-06, oge US, Acadia Pharmaceuticals (Nasdaq: ACAD) kwupụtara nsonaazụ kacha mma nke nnwale ụlọ ọgwụ Phase III nke onye nyocha ọgwụ ya, Trofinetide.A na-ejikarị ule nke III, nke a na-akpọ Lavender, iji nyochaa nchekwa na ịdị irè nke Trofinetide na ọgwụgwọ Ret ...
GỤKWUO